← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 1, 2004Last known activity
Jun 1, 2009
Timeline
Drugs by trial phase (8 distinct, 13 trials)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Hodgkin Disease
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Lymphoma
- Lymphoma, Follicular
- Lymphoma, Mantle-Cell
- Mastocytosis
- Mastocytosis, Systemic
- Melanoma
- Metaplasia
- Myelodysplastic Syndromes
- Neoplasms
- Preleukemia
- Primary Myelofibrosis
- Small Cell Lung Carcinoma
- Syndrome
Recent trials (25)
- NCT00918931CollaboratorPhase 2Jun 1, 2009
- NCT00724841Study directorPhase 1/Phase 2Jun 1, 2008
- NCT00724841Lead sponsorPhase 1/Phase 2Jun 1, 2008
- NCT00682981Lead sponsorPhase 1/Phase 2May 1, 2008
- NCT00682981Study directorPhase 1/Phase 2May 1, 2008
- NCT00684918Study directorPhase 2Apr 1, 2008
- NCT00684918Lead sponsorPhase 2Apr 1, 2008
- NCT00457574Lead sponsorPhase 1Mar 1, 2007
- NCT00457574Study directorPhase 1Mar 1, 2007
- NCT00427856Lead sponsorPhase 2Mar 1, 2007
- NCT00427856Study directorPhase 2Mar 1, 2007
- NCT00413114Lead sponsorPhase 2Dec 1, 2006
- NCT00413114Study directorPhase 2Dec 1, 2006
- NCT00407303Study directorPhase 1/Phase 2Oct 1, 2006
- NCT00405951Study directorPhase 1/Phase 2Oct 1, 2006
Details
- Founded
- Montreal, CA Jun 1, 1998
- Last known activity
- Jun 1, 2009